Rajapreyar Indranee, Joly Joanna, Tallaj Jose, Pamboukian Salpy V, Assad Ayman Haj, Lenneman Carrie, Litovsky Silvio, Chatterjee Arka, Hoopes Charles, Lenneman Andrew
Division of Cardiovascular Disease, Section of Advanced Heart Failure and Transplantation, University of Alabama at Birmingham, Birmingham.
Division of Cardiovascular disease, University of Alabama at Birmingham, Birmingham.
Mayo Clin Proc Innov Qual Outcomes. 2020 Nov 20;5(1):210-218. doi: 10.1016/j.mayocpiqo.2020.09.004. eCollection 2021 Feb.
Pulmonary hypertension (PH) has been described in myeloproliferative disorders; monoclonal plasma cell disorder such as polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome; and plasma cell dyscrasias such as multiple myeloma and amyloidosis. We describe 4 cases of PH likely due to pulmonary vascular involvement and myocardial deposition from light chain deposition disease, amyloidosis, and multiple myeloma. On the basis of our clinical experience and literature review, we propose screening for plasma cell dyscrasia in patients with heart failure with preserved ejection fraction, unexplained PH, and hematological abnormalities. We also recommend inclusion of cardiopulmonary screening in patients with monoclonal gammopathy of undetermined significance.
肺动脉高压(PH)已在骨髓增殖性疾病、单克隆浆细胞疾病(如多神经病、器官肿大、内分泌病、单克隆丙种球蛋白病和皮肤改变综合征)以及浆细胞异常增生症(如多发性骨髓瘤和淀粉样变性)中有所描述。我们报告了4例可能因轻链沉积病、淀粉样变性和多发性骨髓瘤导致肺血管受累及心肌沉积而引起的PH病例。基于我们的临床经验和文献综述,我们建议对射血分数保留的心力衰竭、不明原因的PH和血液学异常患者进行浆细胞异常增生症筛查。我们还建议对意义未明的单克隆丙种球蛋白病患者进行心肺筛查。